Literature DB >> 18159481

Translocation of Clostridium difficile toxin B across polarized Caco-2 cell monolayers is enhanced by toxin A.

Tim Du1, Michelle J Alfa.   

Abstract

Clostridium difficile is the etiological agent of antibiotic-associated diarrhea; the most common form of nosocomial infectious diarrhea. The basis for the shock-like systemic symptoms observed in severe cases of this infection are not known. It is hypothesized that the invasion of C difficile toxins A and/or B from the gut mucosa may contribute to these symptoms.A polarized tissue culture model employing Caco-2 cells grown on transwell inserts was established to study the translocation of purified C difficile toxins A and B. C difficile toxins were (125)I labelled and inoculated onto confluent polarized Caco-2 cell monolayers to study translocation dynamics. Electrical resistance measurements were used to monitor monolayer confluence and tight junction integrity. Samples were taken from the apical and basal sides of the insert, as well as the insert itself, and tested using the human foreskin fibroblasts cell cytotoxicity assay to monitor partitioning of the radiolabelled toxins. Toxin A produced a 50% reduction in electrical resistance in 3 h whereas the same concentration of toxin B required at least 7 h to achieve the same effect. Both toxins A and B were able to translocate across confluent monolayers of Caco-2 cells. The combination of toxin A and B together was synergistic with respect to promoting the translocation of toxin B. Although the addition of toxin A resulted in a 100% increase in the amount of toxin B able to translocate, no increases in toxin A translocation were observed. These findings suggest a model of pathogenesis in which C difficile toxin A facilitates the translocation of toxin B from the gut into submucosal areas where it may play a role in inflammatory damage.

Entities:  

Keywords:  Clostridium difficile; Polarized-monolayers; Toxin A; Toxin B; Translocation

Year:  2004        PMID: 18159481      PMCID: PMC2094961          DOI: 10.1155/2004/292580

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  31 in total

Review 1.  Large clostridial cytotoxins--a family of glycosyltransferases modifying small GTP-binding proteins.

Authors:  C von Eichel-Streiber; P Boquet; M Sauerborn; M Thelestam
Journal:  Trends Microbiol       Date:  1996-10       Impact factor: 17.079

2.  C. difficile toxin A increases intestinal permeability and induces Cl- secretion.

Authors:  R Moore; C Pothoulakis; J T LaMont; S Carlson; J L Madara
Journal:  Am J Physiol       Date:  1990-08

3.  Purification and properties of Clostridium difficile cytotoxin B.

Authors:  C Pothoulakis; L M Barone; R Ely; B Faris; M E Clark; C Franzblau; J T LaMont
Journal:  J Biol Chem       Date:  1986-01-25       Impact factor: 5.157

4.  Rho protein regulates tight junctions and perijunctional actin organization in polarized epithelia.

Authors:  A Nusrat; M Giry; J R Turner; S P Colgan; C A Parkos; D Carnes; E Lemichez; P Boquet; J L Madara
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

5.  Purification of a functional receptor for Clostridium difficile toxin A from intestinal brush border membranes of infant hamsters.

Authors:  R D Rolfe; W Song
Journal:  Clin Infect Dis       Date:  1993-06       Impact factor: 9.079

6.  Active and passive immunization to protect against antibiotic associated caecitis in hamsters.

Authors:  D S Fernie; R O Thomson; I Batty; P D Walker
Journal:  Dev Biol Stand       Date:  1983

7.  Rapid death of infant rhesus monkeys injected with Clostridium difficile toxins A and B: physiologic and pathologic basis.

Authors:  S S Arnon; D C Mills; P A Day; R V Henrickson; N M Sullivan; T D Wilkins
Journal:  J Pediatr       Date:  1984-01       Impact factor: 4.406

8.  Comparison of two toxins produced by Clostridium difficile.

Authors:  N S Taylor; G M Thorne; J G Bartlett
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

9.  Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile.

Authors:  D M Lyerly; L A Barroso; T D Wilkins; C Depitre; G Corthier
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

10.  Effects of Clostridium difficile toxins given intragastrically to animals.

Authors:  D M Lyerly; K E Saum; D K MacDonald; T D Wilkins
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

View more
  8 in total

1.  Identification of an epithelial cell receptor responsible for Clostridium difficile TcdB-induced cytotoxicity.

Authors:  Michelle E LaFrance; Melissa A Farrow; Ramyavardhanee Chandrasekaran; Jinsong Sheng; Donald H Rubin; D Borden Lacy
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-18       Impact factor: 11.205

2.  Persistence and toxin production by Clostridium difficile within human intestinal organoids result in disruption of epithelial paracellular barrier function.

Authors:  Jhansi L Leslie; Sha Huang; Judith S Opp; Melinda S Nagy; Masayuki Kobayashi; Vincent B Young; Jason R Spence
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

3.  Immunization with Bacillus spores expressing toxin A peptide repeats protects against infection with Clostridium difficile strains producing toxins A and B.

Authors:  Patima Permpoonpattana; Huynh A Hong; Jutarop Phetcharaburanin; Jen-Min Huang; Jenny Cook; Neil F Fairweather; Simon M Cutting
Journal:  Infect Immun       Date:  2011-04-11       Impact factor: 3.441

4.  Toxin-mediated paracellular transport of antitoxin antibodies facilitates protection against Clostridium difficile infection.

Authors:  Z Zhang; X Chen; L D Hernandez; P Lipari; A Flattery; S-C Chen; S Kramer; J D Polishook; F Racine; H Cape; C P Kelly; A G Therien
Journal:  Infect Immun       Date:  2014-11-10       Impact factor: 3.441

5.  The role of toxin A and toxin B in Clostridium difficile infection.

Authors:  Sarah A Kuehne; Stephen T Cartman; John T Heap; Michelle L Kelly; Alan Cockayne; Nigel P Minton
Journal:  Nature       Date:  2010-09-15       Impact factor: 49.962

6.  A mixture of functionally oligoclonal humanized monoclonal antibodies that neutralize Clostridium difficile TcdA and TcdB with high levels of in vitro potency shows in vivo protection in a hamster infection model.

Authors:  Nicola L Davies; Joanne E Compson; Brendon Mackenzie; Victoria L O'Dowd; Amanda K F Oxbrow; James T Heads; Alison Turner; Kaushik Sarkar; Sarah L Dugdale; Mark Jairaj; Louis Christodoulou; David E O Knight; Amanda S Cross; Karine J M Hervé; Kerry L Tyson; Hanna Hailu; Carl B Doyle; Mark Ellis; Marco Kriek; Matthew Cox; Matthew J T Page; Adrian R Moore; Daniel J Lightwood; David P Humphreys
Journal:  Clin Vaccine Immunol       Date:  2013-01-16

7.  Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A.

Authors:  Ruth Murray; Dave Boyd; Paul N Levett; Michael R Mulvey; Michelle J Alfa
Journal:  BMC Infect Dis       Date:  2009-06-28       Impact factor: 3.090

8.  Toxin B is essential for virulence of Clostridium difficile.

Authors:  Dena Lyras; Jennifer R O'Connor; Pauline M Howarth; Susan P Sambol; Glen P Carter; Tongted Phumoonna; Rachael Poon; Vicki Adams; Gayatri Vedantam; Stuart Johnson; Dale N Gerding; Julian I Rood
Journal:  Nature       Date:  2009-03-01       Impact factor: 49.962

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.